全文获取类型
收费全文 | 146668篇 |
免费 | 13557篇 |
国内免费 | 5848篇 |
专业分类
耳鼻咽喉 | 1045篇 |
儿科学 | 2646篇 |
妇产科学 | 1446篇 |
基础医学 | 19971篇 |
口腔科学 | 1941篇 |
临床医学 | 15738篇 |
内科学 | 28918篇 |
皮肤病学 | 1895篇 |
神经病学 | 6685篇 |
特种医学 | 3956篇 |
外国民族医学 | 19篇 |
外科学 | 8902篇 |
综合类 | 23509篇 |
现状与发展 | 26篇 |
一般理论 | 2篇 |
预防医学 | 14524篇 |
眼科学 | 2163篇 |
药学 | 17060篇 |
133篇 | |
中国医学 | 8556篇 |
肿瘤学 | 6938篇 |
出版年
2023年 | 2066篇 |
2022年 | 3087篇 |
2021年 | 5569篇 |
2020年 | 5713篇 |
2019年 | 5381篇 |
2018年 | 5367篇 |
2017年 | 5307篇 |
2016年 | 5944篇 |
2015年 | 6087篇 |
2014年 | 10550篇 |
2013年 | 10884篇 |
2012年 | 10307篇 |
2011年 | 10598篇 |
2010年 | 8397篇 |
2009年 | 7523篇 |
2008年 | 7392篇 |
2007年 | 7423篇 |
2006年 | 6572篇 |
2005年 | 5557篇 |
2004年 | 4608篇 |
2003年 | 4132篇 |
2002年 | 3228篇 |
2001年 | 2972篇 |
2000年 | 2385篇 |
1999年 | 2072篇 |
1998年 | 1612篇 |
1997年 | 1463篇 |
1996年 | 1185篇 |
1995年 | 1388篇 |
1994年 | 1207篇 |
1993年 | 911篇 |
1992年 | 825篇 |
1991年 | 649篇 |
1990年 | 640篇 |
1989年 | 567篇 |
1988年 | 467篇 |
1987年 | 436篇 |
1986年 | 348篇 |
1985年 | 767篇 |
1984年 | 720篇 |
1983年 | 563篇 |
1982年 | 578篇 |
1981年 | 448篇 |
1980年 | 427篇 |
1979年 | 336篇 |
1978年 | 293篇 |
1977年 | 210篇 |
1976年 | 226篇 |
1975年 | 180篇 |
1974年 | 161篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
991.
992.
Jianbing Su Keng Wang Xuan Zhou Yiyuan Wang Jialan Xu Lei Tao Xiangzhou Zeng Nana Chen Xiaochun Bai Xiaojuan Li 《Immunology》2019,156(3):282-296
Nuclear receptor peroxisome proliferator-activated receptor γ (PPAR-γ) activation can prevent immunoinflammatory disorders and diabetes. B cells play protective roles during inflammation as well. However, the roles of endogenous PPAR-γ in the regulatory properties of B cells to relieve inflammation remain unknown. Here, we developed B-cell-specific PPAR-γ knockout (B-PPAR-γ−/−) mice and found that the conditional deletion of PPAR-γ in B cells resulted in exaggerated contact hypersensitivity (CHS). Meanwhile, interferon-γ (IFN-γ) of CD4+ CD8+ T cells was up-regulated in B-PPAR-γ−/− mice in CHS. This showed that the regulatory function of B cells in B-PPAR-γ−/− mice declined in vivo. Whereas splenic CD5+ CD1dhi regulatory B-cell numbers and peripheral regulatory T-cell numbers were not changed in naive B-PPAR-γ−/− mice. Loss of PPAR-γ in B cells also did not affect either CD86 or FasL expression in splenic CD5+ CD1dhi regulatory B cells after activation. Notably, interleukin-10 (IL-10) production in CD5+ CD1dhi regulatory B cells reduced in B-PPAR-γ-deficient mice. In addition, functional IL-10-producing CD5+ CD1dhi regulatory B cells decreased in B-PPAR-γ−/− mice in the CHS model. These findings were in accordance with augmented CHS. The current work indicated the involvement of endogenous PPAR-γ in the regulatory function of B cells by disturbing the expansion of IL-10-positive regulatory B cells. 相似文献
993.
994.
Paulo Roberto P. Urbano Luiz H. da Silva Nali Renato dos R Oliveira MS Laura M. Sumita Maria Cristina D. da Silva Fink Lígia C Pierrotti MD MS Camila da Silva Bicalho Elias David-Neto MD Cláudio S. Pannuti MD Camila M Romano 《Journal of medical virology》2019,91(6):1136-1141
BK virus is the causative agent of polyomavirus-associated nephropathy, a major cause of kidney transplant failure affecting 1%-10% of recipients. Previous studies that investigated the viral source on the kidney recipient pointed that the donor is implicated in the origin of human polyomavirus BK (BKPyV) infection in recipients, but giving the low genetic variability of BKPyV this subject is still controversial. The aim of this study was to determine if BKPyV replicating in kidney recipients after transplantation is always originated from the donor. Urine and blood samples from 68 pairs of living donors and kidney recipients who underwent renal transplantation from August 2010-September 2011 were screened for BKPyV by real time polymerase chain reaction. Only three recipients presented viremia. When both donors and recipients were BKPyV positive, a larger fragment of VP1 region was obtained and sequenced to determine the level of similarity between them. A phylogenetic tree was built for the 12 pairs of sequences obtained from urine and high level of similarity among all sequences was observed, indicating that homology inferences for donor and recipient viruses must be cautiously interpreted. However, a close inspection on the donor-recipient pairs sequences revealed that 3 of 12 pairs presented considerably different viruses and 4 of 12 presented mixed infection, indicating that the source of BKPyV infection is not exclusively derived from the donor. We report that about 60% of the renal recipients shed BKPyV genetically distinct from the donor, confronting the accepted concept that the donor is the main source of recipients’ infection. 相似文献
995.
996.
María de los Ángeles Ribas Yahisel Tejero Yanislet Cordero Daileny Pérez Aurélie Sausy Claude P. Muller Judith M. Hübschen 《Journal of medical virology》2019,91(7):1351-1354
Between September 2014 and December 2015, 298 sera from rash and fever patients from all over Cuba were investigated for specific IgM antibodies against measles, rubella, dengue, human parvovirus B19 (B19V) and human herpesvirus 6 (HHV6) using a commercial enzyme-linked immunosorbent assay kits. B19V IgM positive and equivocal samples were investigated by a polymerase chain reaction and genotyping. No measles, rubella or dengue cases were detected. HHV6-IgM antibodies were confirmed in 5.7% and B19V-IgM antibodies in 10.7% of the patients. A total of 31.3% of the B19V cases were between 5 and 9 years old and 34.4% were 20 years and older. The only B19V sequence obtained belonged to genotype 1a. Diagnosis was established for only 16% of the rash and fever patients, suggesting that other diseases such as Zika or Chikungunya may play a role. 相似文献
997.
998.
Primary immunodeficiencies (PIDs) provide researchers with unique models to understand in vivo immune responses in general and immunity to infections in particular. In humans, impaired immune control of Epstein‐Barr virus (EBV) infection is associated with the occurrence of several different immunopathologic conditions; these include non‐malignant and malignant B‐cell lymphoproliferative disorders, hemophagocytic lymphohistiocytosis (HLH), a severe inflammatory condition, and a chronic acute EBV infection of T cells. Studies of PIDs associated with a predisposition to develop severe, chronic EBV infections have led to the identification of key components of immunity to EBV – notably the central role of T‐cell expansion and its regulation in the pathophysiology of EBV‐associated diseases. On one hand, the defective expansion of EBV‐specific CD8 T cells results from mutations in genes involved in T‐cell activation (such as RASGRP1, MAGT1, and ITK), DNA metabolism (CTPS1) or co‐stimulatory pathways (CD70, CD27, and TNFSFR9 (also known as CD137/4‐1BB)) leads to impaired elimination of proliferating EBV‐infected B cells and the occurrence of lymphoma. On the other hand, protracted T‐cell expansion and activation after the defective killing of EBV‐infected B cells is caused by genetic defects in the components of the lytic granule exocytosis pathway or in the small adapter protein SH2D1A (also known as SAP), a key activator of T‐ and NK cell‐cytotoxicity. In this setting, the persistence of EBV‐infected cells results in HLH, a condition characterized by unleashed T‐cell and macrophage activation. Moreover, genetic defects causing selective vulnerability to EBV infection have highlighted the role of co‐receptor molecules (CD27, CD137, and SLAM‐R) selectively involved in immune responses against infected B cells via specific T‐B cell interactions. 相似文献
999.
1000.